|
Post by Admin on Feb 3, 2019 13:03:48 GMT
Use of dronabinol (delta-9-THC) in autism- A prospective single-case-study with an early infantile autistic child Abstract Objective: To evaluate the effectiveness of dronabinol (delta-9-THC) as supplementary therapy in a child with autistic disorder. Methods: A child who met the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) criteria for a diagnosis of autistic disorder and who took no other medication during the observa-tion time was included in an open and uncontrolled study. Symptom assessment was performed using the Aberrant Behavior Checklist (ABC) before and after six months of medical treatment. Result: Compared to baseline, significant improvements were observed for hyperactivity, leth-argy, irritability, stereotypy and inappropriate speech at follow-up (p=0.043). Conclusion: This study showed that the use of dronabinol may be able to reduce the symptoms of autism. Source: www.researchgate.net/publication/268299424_Use_of_dronabinol_delta-9-THC_in_autism_A_prospective_single-case-study_with_an_early_infantile_autistic_child
|
|